Qatar’s National Expanded Metabolic Newborn Screening Program: Incidence and Outcomes
Our study provides the incidence rates of IEMs in Qatar and novel insights that could facilitate setting up/developing IEM incidence-reducing strategies and improving outcomes for affected newborns and their families.
Authors
- Tala M. Jamaleddin (ORCID: https://orcid.org/0000-0002-9272-1168)
- Mashael Al‐Shafai (ORCID: https://orcid.org/0000-0002-8626-6429)
- Sara Musa (ORCID: https://orcid.org/0000-0001-5165-4109)
- Hilal Al Rifai (ORCID: https://orcid.org/0009-0005-9273-2499)
- Tawfeg Ben‐Omran (ORCID: https://orcid.org/0000-0001-8522-7738)
- Rola Mitri
- Mamatha Ramaswamy
- Karen El‐Akouri (ORCID: https://orcid.org/0000-0003-1476-3490)
- Noora Shahbeck (ORCID: https://orcid.org/0000-0002-4534-3731)
- Ghassan Abdoh
- Sumaya Abiib (ORCID: https://orcid.org/0000-0003-4661-6030)
- Rehab Ali
- Osama Y. Al-Dirbashi
Institutions
- Qatar Airways (Qatar) (QA)
- Hamad bin Khalifa University (QA)
- Weill Cornell Medical College in Qatar (QA)
- Hamad Medical Corporation (QA)
- Qatar University (QA)
Publication Details
- Journal
- International Journal of Neonatal Screening
- Published
- 2025-06-30
- DOI
- https://doi.org/10.3390/ijns11030050
- Primary Topic
- Metabolism and Genetic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hamad Medical Corporation